Optipharm.CO.,LTD

₩4,340As of Sun 8 Nov 2026, 12:00 UTC
KOSDAQ:153710Healthcare
Country South Korea
PE (Fwd) •••
TSR 8Y CAGR (11.20%)
Div yield —
ROE (7.35%)
Pharmaceutical Preparations
Beta (5Y) 0.07
PE TTM —
TSR TTM (13.72%)
Mkt cap ₩63.67B
ROIC (3.09%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
₩4,867
12.15%
83.89%
Hold 4|11|6|5|8
4Q25
1Q26
2Q26
3Q26
Earnings per share₩
62.62
61.85
59.74
63.69
7.71%
11.09%
(2.64%)
(0.45%)
Revenue₩B
6.285
6.214
6.388
6.477
5.83%
5.44%
7.56%
5.82%
Peers (US$46.94M)
Cap (US$)
PE
Capital
TTM
5Y
10Y
Leveragex
1.918
0.067
0.051
EBIT/Intx
0.203
0.122
0.117
Own earn%
(113.78)
(15.16)
(13.50)
Sh yield%
36.02
20.81
20.88
Owners
Insiders/Inst%
7.79
32.12
Short interest%
5.07
SBC / revenue%
4.33
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
1
Op margin range%
4–11
$1 testx
—
Incr. ROIC%
18